Clinical Trials on Work-related Musculoskeletal Disorders in Norway
Total 778 results
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, France, India, Philippines
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Croatia, Italy, Slovakia, Denmark, Macedonia, The Former Yugoslav Republic of, Norway, Russian Federation, Finland, France, Poland, Greece, Romania, Sweden, Czech Republic, Argentina
-
Eli Lilly and CompanyCompletedType 2 DiabetesUnited States, Puerto Rico
-
Solvay PharmaceuticalsCompletedPatients With Metabolic SyndromeHungary, Canada, Finland, Italy, Netherlands, Norway, Poland, Romania, Sweden
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedAnemia | Lung Cancer | Neutropenia | Drug/Agent Toxicity by Tissue/OrganUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesItaly, Poland, Denmark, France, Netherlands, Austria, Spain, Finland, Argentina, India, Russian Federation, United Kingdom, Slovakia, Brazil, Norway, Former Serbia and Montenegro, South Africa, Philippines
-
SanofiCompletedDiabetes Mellitus, Type 2Australia, United Kingdom
-
TakedaCompletedDiabetes MellitusUnited States, Puerto Rico
-
AstraZenecaEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Belgium, United States, Australia, Portugal, Germany, Puerto Rico, Spain, Netherlands, Brazil, Finland, Norway, Poland, Sweden
-
AstraZenecaTerminatedType 2 DiabetesFrance, Korea, Republic of, South Africa, Spain, United Kingdom, Vietnam, Norway, Israel, Philippines, Australia
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesMexico, South Africa, Norway, Argentina, Belgium, Denmark, Sweden, France, Italy
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLung Cancer | Radiation Toxicity | Drug/Agent Toxicity by Tissue/OrganUnited States
-
Eli Lilly and CompanyCompletedType 2 DiabetesUnited States, Hungary, Poland, Slovakia, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United Kingdom, Denmark, Canada, France, Netherlands, Austria, Israel, Finland, Russian Federation, Croatia, Bulgaria, Poland, Ireland, Spain, Norway, Greece, Argentina, Germany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 1United Kingdom, Denmark, Sweden, Netherlands, Belgium, Finland, France, Australia, Ireland, Norway
-
GlaxoSmithKlineCompletedMuscular DystrophiesFrance, Denmark, Germany, Belgium, Spain, Turkey, Korea, Republic of, Brazil, Netherlands, Italy, Chile, Japan, Canada, Hungary, Russian Federation, Czechia, Poland, Norway, Argentina, Taiwan
-
PfizerCompletedDiabetes Mellitus, Type 2Germany, Netherlands, Sweden, Poland, Belgium, Finland, France, Norway, Spain, Switzerland
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, Australia, Germany, Canada, France
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Austria, Croatia, Czech Republic, Estonia, Finland, France, Germany, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Norway, Romania, Russian Federation, Slovakia, Spain, Sweden, Taiwan, Ukraine
-
Biomea Fusion Inc.SuspendedType 1 Diabetes MellitusUnited States, Canada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedColorectal Cancer | Neurotoxicity | Neuropathy | Chemotherapeutic Agent ToxicityUnited States, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Puerto Rico, Spain, Denmark, Austria, Belgium, Serbia, Germany, Slovenia, Canada, France, Finland, Former Serbia and Montenegro, Czech Republic, Norway
-
TheracosCompletedType2 Diabetes MellitusUnited States, Japan
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Puerto Rico, Mexico
-
Intarcia TherapeuticsCompletedType 2 DiabetesUnited States
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Poland, United Kingdom, Belgium, Norway, Germany, Greece
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesKorea, Republic of, Russian Federation, United Kingdom, Vietnam, Germany, Hungary, Finland, Norway, Netherlands, Slovakia, India
-
Intarcia TherapeuticsTerminatedType 2 DiabetesUnited States
-
Eli Lilly and CompanyActive, not recruitingType 2 DiabetesUnited States, Belgium, Germany, Mexico, Romania
-
NovartisCompletedDiabetes Mellitus, Type 2United States, Philippines, India, Puerto Rico, Canada, Malaysia, Romania, Slovakia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Israel, Poland, Russian Federation, United Kingdom, Denmark, Finland, Sweden
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Korea, Republic of, Latvia, Peru, Lithuania, Israel, Norway, Finland, Argentina, Austria, Belgium, Germany, Greece, Guatemala, Hungary, India, Italy, Mexico, Poland, Romania, Slovakia, Venezuela
-
AstraZenecaTerminatedDiabetes Mellitus, Type 2United States, Spain, United Kingdom, Germany, Finland, Norway, Israel, Netherlands
-
BayerCompletedErectile DysfunctionIsrael, Italy, Colombia, Spain, Belgium, Finland, Mexico, Germany, South Africa, Netherlands, Norway, Peru, Sweden
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Chile, Czech Republic, Denmark, France, Germany, Hungary, Lithuania, Mexico, Poland, Romania, Slovakia, Sweden
-
GlaxoSmithKlineWithdrawnType 2 Diabetes MellitusUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Puerto Rico
-
PfizerTerminatedObesity | Diabetes MellitusUnited States, Hungary, Canada, Japan, Poland, Puerto Rico, Bulgaria, Czechia
-
Lexicon PharmaceuticalsSanofiCompletedType 2 Diabetes MellitusUnited States, Bulgaria, Hungary, Slovakia
-
TakedaCompletedDiabetes MellitusUnited States, Chile, Mexico, Puerto Rico
-
TakedaCompletedDiabetes Mellitus, Type 2United States
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada, India, Israel, Malaysia, Mexico, Philippines, Puerto Rico, Russian Federation, Sri Lanka, Thailand, Ukraine
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Spain, Denmark, Austria, Belgium, Serbia, Germany, Canada, France, Finland, Norway, Czech Republic
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedPain | Unspecified Adult Solid Tumor, Protocol Specific | Neurotoxicity | Chemotherapeutic Agent ToxicityUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBreast Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Drug/Agent Toxicity by Tissue/OrganUnited States
-
Eli Lilly and CompanyCompletedType 2 DiabetesUnited States, Puerto Rico, Spain, Japan, Germany, Czechia, Poland, Slovakia
-
AmgenCompletedType 2 Diabetes | Hypercholesterolemia | Mixed DyslipidemiaUnited States, Italy, Belgium, Spain, Canada, Poland, Mexico
-
Hoffmann-La RocheCompletedOvarian CancerFrance, Spain, Brazil, United Kingdom, Netherlands, Italy, Russian Federation, Sweden, Norway
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, Poland, Germany, Israel, Bulgaria, Costa Rica, India, Romania, Ukraine, Finland, Korea, Republic of, Canada, Philippines, Russian Federation, Argentina, Norway, Denmark, Slovakia, Mexico, Puerto Rico
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Bulgaria, Denmark, France, Germany, Hong Kong, Hungary, India, Ireland, Italy, Netherlands, Norway, Poland, South Africa, Sweden, United Kingdom